These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1479999)

  • 1. Oral flucloxacillin in septicaemia.
    Gobbo O; Street A; Bury RW; Moulds RF
    Med J Aust; 1992 Oct; 157(8):575. PubMed ID: 1479999
    [No Abstract]   [Full Text] [Related]  

  • 2. The clinical efficacy of continuous-infusion flucloxacillin in serious staphylococcal sepsis.
    Leder K; Turnidge JD; Korman TM; Grayson ML
    J Antimicrob Chemother; 1999 Jan; 43(1):113-8. PubMed ID: 10381108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The simplified oral flucloxacillin absorption test: an accurate method to identify patients with inadequate oral flucloxacillin absorption.
    Dijkmans AC; Kweekel DM; Balmforth C; van Esdonk MJ; van Dissel JT; Burggraaf J; Kamerling IMC
    Neth J Med; 2019 Sep; 77(7):255-260. PubMed ID: 31582580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Septicaemia in patients with temporary and permanent endocardial pacemakers.
    Smyth EG; Pallister D
    J R Soc Med; 1989 Jul; 82(7):396-8. PubMed ID: 2585423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma and bone concentrations of cefuroxime and flucloxacillin. Oral versus parenteral administration in 20 arthroplasties.
    Alvarez Ferrero MM; Vree TB; Baars AM; Slooff TJ
    Acta Orthop Scand; 1993 Oct; 64(5):525-9. PubMed ID: 8237317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beyond Penicillin: Rapid Desensitization for Specific Flucloxacillin Hypersensitivity.
    Kwong JC; Urbancic K; Trubiano JA
    Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30224537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and bioavailability of flucloxacillin in elderly hospitalized patients.
    Gath J; Charles B; Sampson J; Smithurst B
    J Clin Pharmacol; 1995 Jan; 35(1):31-6. PubMed ID: 7751411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total flucloxacillin plasma concentrations poorly reflect unbound concentrations in hospitalized patients with Staphylococcus aureus bacteraemia.
    Chin PKL; Drennan PG; Gardiner SJ; Zhang M; Dalton SC; Chambers ST; Begg EJ
    Br J Clin Pharmacol; 2018 Oct; 84(10):2311-2316. PubMed ID: 29908071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between plasma and bone concentrations of cefuroxime and flucloxacillin. Three different parenteral administrations compared in 30 arthroplasties.
    Alvarez Ferrero MM; Vree TB; Van Ewijk-Beneken Kolmer EW; Slooff TJ
    Biopharm Drug Dispos; 1994 Oct; 15(7):599-608. PubMed ID: 7849235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous flucloxacillin treatment is associated with a high incidence of hypokalaemia.
    van der Heijden CDCC; Duizer ML; Fleuren HWHA; Veldman BA; Sprong T; Dofferhoff ATSM; Kramers C
    Br J Clin Pharmacol; 2019 Dec; 85(12):2886-2890. PubMed ID: 31026083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flucloxacillin in the treatment of infectious conditions in children.
    Price JD; Harding JW
    Curr Med Res Opin; 1975; 3(2):77-82. PubMed ID: 1139964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective CSF concentrations achieved with continuous-infusion flucloxacillin in a child.
    Boast A; Carr J; Curtis N; Daley AJ; Gwee A
    Eur J Clin Pharmacol; 2015 Dec; 71(12):1535-7. PubMed ID: 26303111
    [No Abstract]   [Full Text] [Related]  

  • 13. Experimental studies of amoxycillin-flucloxacillin combination.
    Ripa S; Prenna M; Vitali C
    Antibiotica; 1974 Jun; 12(2):88-106. PubMed ID: 4470369
    [No Abstract]   [Full Text] [Related]  

  • 14. The efficacy of continuous infusion flucloxacillin in home therapy for serious staphylococcal infections and cellulitis.
    Howden BP; Richards MJ
    J Antimicrob Chemother; 2001 Aug; 48(2):311-4. PubMed ID: 11481308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized clinical trial to compare fleroxacin-rifampicin with flucloxacillin or vancomycin for the treatment of staphylococcal infection.
    Schrenzel J; Harbarth S; Schockmel G; Genné D; Bregenzer T; Flueckiger U; Petignat C; Jacobs F; Francioli P; Zimmerli W; Lew DP;
    Clin Infect Dis; 2004 Nov; 39(9):1285-92. PubMed ID: 15494904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dicloxacillin and flucloxacillin: pharmacokinetics, protein binding and serum bactericidal titers in healthy subjects after oral administration.
    Røder BL; Frimodt-Møller N; Espersen F; Rasmussen SN
    Infection; 1995; 23(2):107-12. PubMed ID: 7622258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic drug monitoring of flucloxacillin.
    van Daele PLA
    Neth J Med; 2019 Sep; 77(7):233. PubMed ID: 31582583
    [No Abstract]   [Full Text] [Related]  

  • 18. Early termination of a prospective, randomized trial comparing teicoplanin and flucloxacillin for treating severe staphylococcal infections.
    Calain P; Krause KH; Vaudaux P; Auckenthaler R; Lew D; Waldvogel F; Hirschel B
    J Infect Dis; 1987 Feb; 155(2):187-91. PubMed ID: 2949024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy of the combination of teicoplanin or flucloxacillin with netilmicin in the treatment of Staphylococcus aureus bacteraemia.
    Degener JE; Vogel M; Michel MF; Mutsaers MM; Hop WC
    J Antimicrob Chemother; 1989 Jun; 23(6):899-904. PubMed ID: 2527224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flucloxacillin dosing in critically ill patients with hypoalbuminaemia: special emphasis on unbound pharmacokinetics.
    Ulldemolins M; Roberts JA; Wallis SC; Rello J; Lipman J
    J Antimicrob Chemother; 2010 Aug; 65(8):1771-8. PubMed ID: 20530507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.